Patent: 6,365,160
✉ Email this page to a colleague
Summary for Patent: 6,365,160
| Title: | Papillomavirus polyprotein constructs |
| Abstract: | Peptides, antibodies and recombinant expression systems or cells that contain and express a DNA insert of HPV encoding a region of a papilloma induced or a papilloma protein, such as E6 or E7, are produced. Compositions containing these peptides, antibodies and/or recombinant cells are utilized as immunogenic compositions and in methods for inhibiting and treating HPV infection and tumor initiation and progression. Specific peptides and recombinant cells, such as vaccinia virus and tumor cells, that express epitopic regions of the HPV16 E6 or E7 nucleoprotein are particularly described. |
| Inventor(s): | Elizabeth Ann Webb, Mary Brigid Margetts, John Cooper Cox, Ian Frazer, Nigel Alan John McMillan, Mark Philip Williams, Margaret Bridget Holland Moloney, Stirling John Edwards |
| Assignee: | OF QUEENSLAND THE, University of , University of Queensland UQ , CSL Ltd |
| Application Number: | US09/000,094 |
| Patent Claims: | see list of patent claims |
Details for Patent 6,365,160
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Rare Disease Therapeutics, Inc. (rdt) | ANASCORP | centruroides (scorpion) immune f(ab')2 (equine) injection | For Injection | 125335 | August 03, 2011 | 6,365,160 | 2016-07-26 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
